产品中心Products Resources
联系我们CONTACT US
-
400 179 0116
24小时服务热线
当前位置:首页 > 产品中心(Products) > 细胞定制Cell Customization(Cell Customization) > 肿瘤细胞(Tumor Cell Lines) > 人源肿瘤细胞(human Tumor cells) > CERV-196
产品描述/Products Description
The CERV-196 cell line was established from a poorly differentiated squamous cell carcinoma of the cervix; HPV-16 positive. In vitro established from the xenotransplant cervix carcinoma MRI-H-196 by Cell Lines Service. Primary xenotransplant was adopted to in vivo transplantation by Dr. Bodgen, Mason Research Institute.